Pivot Path will focus on life sciences and manufacturing solutions, using its cutting-edge technology capabilities.

Although the uncertainty took a bite out of Big Pharma stocks, the industry was mostly spared from the worst of the upheaval. “The Trump administration’s North American, universal and China ...